347 related articles for article (PubMed ID: 36320041)
1. Targeting hypoxia in solid and haematological malignancies.
Harris B; Saleem S; Cook N; Searle E
J Exp Clin Cancer Res; 2022 Nov; 41(1):318. PubMed ID: 36320041
[TBL] [Abstract][Full Text] [Related]
2. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia stimulates CXCR4 signalling in ileal carcinoids.
Arvidsson Y; Bergström A; Arvidsson L; Kristiansson E; Ahlman H; Nilsson O
Endocr Relat Cancer; 2010 Jun; 17(2):303-16. PubMed ID: 20071457
[TBL] [Abstract][Full Text] [Related]
4. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model.
Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J
Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564
[TBL] [Abstract][Full Text] [Related]
7. The role of hypoxia and exploitation of the hypoxic environment in hematologic malignancies.
Muz B; de la Puente P; Azab F; Luderer M; Azab AK
Mol Cancer Res; 2014 Oct; 12(10):1347-54. PubMed ID: 25158954
[TBL] [Abstract][Full Text] [Related]
8. HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells.
Harrison H; Pegg HJ; Thompson J; Bates C; Shore P
BMC Cancer; 2018 Jun; 18(1):674. PubMed ID: 29925335
[TBL] [Abstract][Full Text] [Related]
9. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
[TBL] [Abstract][Full Text] [Related]
10. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.
Casillas AL; Toth RK; Sainz AG; Singh N; Desai AA; Kraft AS; Warfel NA
Clin Cancer Res; 2018 Jan; 24(1):169-180. PubMed ID: 29084916
[No Abstract] [Full Text] [Related]
12. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
13. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression.
Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT
Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496
[TBL] [Abstract][Full Text] [Related]
14. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
[TBL] [Abstract][Full Text] [Related]
15. Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
17. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
18. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
